VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) AS A MARKER FOR MALIGNANT VASCULAR TUMORS AND MESOTHELIOMA – IMMUNOHISTOCHEMICAL STUDY OF 262 VASCULAR ENDOTHELIAL AND 1640 NONVASCULAR TUMORS

類似資料

• PROX1 TRANSCRIPTION FACTOR AS A MARKER FOR VASCULAR TUMORS – EVALUATION OF 314 VASCULAR ENDOTHELIAL AND 1086 NONVASCULAR TUMORS
  著者:: Miettinen, Markku, 等
  出版事項: (2012)
• Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas
  著者:: Lasota, Jerzy, 等
  出版事項: (1999)
• Apparent KIT Ser(715) Deletion in GIST mRNA Is Not Detectable in Genomic DNA and Represents a Previously Known Splice Variant of KIT Transcript
  著者:: Lasota, Jerzy, 等
  出版事項: (2002)
• Claudin-5 as an Immunohistochemical Marker for Angiosarcoma and Hemangioendotheliomas
  著者:: Miettinen, Markku, 等
  出版事項: (2011)
• SALL4 EXPRESSION IN GERM CELL AND NON GERM-CELL TUMORS – A SYSTEMATIC IMMUNOHISTOCHEMICAL STUDY OF 3215 CASES
  著者:: Miettinen, Markku, 等
  出版事項: (2014)